Lecture 1 - Introduction: Genes and Genome Organization
Lecture 2 - History and Basics of Genetic Engineering
Lecture 3 - Advantages and Limitations of Genetic Engineering
Lecture 4 - Breakage of Genomic DNA
Lecture 5 - Repair of Genomic DNA
Lecture 6 - Homologous and non homologous recombination
Lecture 7 - Site specific recombination
Lecture 8 - Targeted genetic modification - I
Lecture 9 - Targeted genetic modification - II
Lecture 10 - Basics of Zinc Finger Nucleases
Lecture 11 - Design of Zinc Finger Nucleases for genome editing
Lecture 12 - Applications of Zinc Finger Nucleases - Part A
Lecture 13 - Applications of Zinc Finger Nucleases - Part B
Lecture 14 - Basics of TALEN - Part A
Lecture 15 - Basics of TALEN - Part B
Lecture 16 - Design of TALEN for genome editing - Part A
Lecture 17 - Design of TALEN for genome editing - Part B
Lecture 18 - Application of TALEN - Part A
Lecture 19 - Application of TALEN - Part B
Lecture 20 - CRISPR system in bacteria - Part A
Lecture 21 - CRISPR system in bacteria - Part B
Lecture 22 - CRISPR/Cas9 in Genome Editing - Part A
Lecture 23 - CRISPR/Cas9 in Genome Editing - Part B
Lecture 24 - Applications of CRISPR/Cas9 - Part A
Lecture 25 - Applications of CRISPR/Cas9 - Part B
Lecture 26 - Computational Resources for CRISPR / Cas - Part A
Lecture 27 - Computational Resources for CRISPR / Cas - Part B
Lecture 28 - Human cell engineering in diseases : Thalassemia - Part A
Lecture 29 - Human cell engineering in diseases : Thalassemia - Part B
Lecture 30 - Human cell engineering in diseases : Severe combined immunodeficiency (SCID) - Part A
Lecture 31 - Human cell engineering in diseases : Severe combined immunodeficiency (SCID) - Part B
Lecture 32 - Human cell engineering in diseases : Hemophilia - Part A
Lecture 33 - Human cell engineering in diseases : Hemophilia - Part B
Lecture 34 - Animal models - Part A
Lecture 35 - Animal models - Part B
Lecture 36 - iPSc models - Part A
Lecture 37 - iPSc models - Part B
Lecture 38 - Cancer disease models - Part A
Lecture 39 - Cancer disease models - Part B
Lecture 40 - Engineered immune cells for Cancer therapy (I) - Part A
Lecture 41 - Engineered immune cells for Cancer therapy (I) - Part B
Lecture 42 - Engineered immune cells for Cancer therapy (II) - Part A
Lecture 43 - Engineered immune cells for Cancer therapy (II) - Part B
Lecture 44 - History and Basics - Part A
Lecture 45 - History and Basics - Part B
Lecture 46 - Genome editing and personalized therapy
Lecture 47 - Bioethics and Biosafety - Part A
Lecture 48 - Bioethics and Biosafety - Part B
Lecture 49 - Regulatory issues in Genome Editing
